Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics
Source abstract
Abstract
The advancements in the areas of real-time RNA biosensor technology and their application to more precise diabetes care have laid the groundwork for new and potentially efficient strategies for monitoring and management of the disease. At the same time, many researchers are now studying the influence of environmental factors, and more specifically, exposure to endocrine-disrupting chemicals (EDCs), that can impact not only the diabetes disease process itself, but also the reliability and consistency of biosensors to monitor these stressors. The current review summarizes recent advances in RNA sensor technology designed for diabetes care, evaluates the connection between it and point-of-care (POC) diagnostics, and purposefully analyzes the existing evidence on how such EDCs can affect biosensor accuracy, stability, and general clinical usefulness.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrochemical sensors and biosensors · Advanced Chemical Sensor Technologies · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioinformatics, Faculty of Engineering & Technology, Marwadi University
Department of Information and Communication Technology, Faculty of Engineering & Technology, Marwadi University
Pendidikan Dasar, Program Pascasarjana, Universitas Majalengka
Department of STEM, Bakhtar University
References (67)
Show source-provided references
1. 10.22192/ijcrcps10.22192/ijcrcps ↗
2. 10.1016/j.chembiol.2013.05.00110.1016/j.chembiol.2013.05.001 ↗
3. 10.1177/1479164125133472610.1177/14791641251334726 ↗
4. Free TJ. Engineering cell-free protein synthesis biosensors for point of engineering cell-free protein synthesis biosensors for point of care use care use. 2024. https://scholarsarchive.byu.edu/etd.
5. 10.3390/bios1211098610.3390/bios12110986 ↗
6. 10.1002/admt.20240050410.1002/admt.202400504 ↗
7. 10.3390/bios1308081210.3390/bios13080812 ↗
8. 10.1016/j.chembiol.2016.10.01410.1016/j.chembiol.2016.10.014 ↗
9. 10.3389/fendo.2025.152043610.3389/fendo.2025.1520436 ↗
10. 10.3390/cells812153310.3390/cells8121533 ↗
11. 10.3390/ijms2407618610.3390/ijms24076186 ↗
12. 10.3389/fendo.2021.63003210.3389/fendo.2021.630032 ↗
13. 10.1080/1354750X.2017.127921610.1080/1354750X.2017.1279216 ↗
14. 10.1186/s12920-023-01476-010.1186/s12920-023-01476-0 ↗
15. 10.3390/jpm1408087810.3390/jpm14080878 ↗
16. Alemdar S Pekel Bayramgil N Karakuş S. Applications of cutting-edge biosensors in healthcare and biomedical research. www.intechopen.com.
17. 10.2337/db16-073110.2337/db16-0731 ↗
18. 10.3390/chemosensors1004013610.3390/chemosensors10040136 ↗
19. 10.1038/s43246-024-00468-610.1038/s43246-024-00468-6 ↗
20. 10.1002/INMD.2023003110.1002/INMD.20230031 ↗
21. 10.3389/fphar.2024.134811210.3389/fphar.2024.1348112 ↗
22. 10.1021/acs.analchem.4c0428910.1021/acs.analchem.4c04289 ↗
23. 10.1002/adma.20190208310.1002/adma.201902083 ↗
24. 10.1016/j.tibtech.2019.12.02110.1016/j.tibtech.2019.12.021 ↗
25. 10.34172/ajmb.252710.34172/ajmb.2527 ↗
26. 10.5114/aoms/14679610.5114/aoms/146796 ↗
27. 10.1210/en.2011-169110.1210/en.2011-1691 ↗
28. 10.1002/advs.20200443310.1002/advs.202004433 ↗
29. 10.26402/jpp.2019.6.0110.26402/jpp.2019.6.01 ↗
30. 10.3390/app1606302710.3390/app16063027 ↗
31. 10.1111/imm.1394410.1111/imm.13944 ↗
32. 10.3390/bios1110036410.3390/bios11100364 ↗
33. 10.1177/19322968090030042010.1177/193229680900300420 ↗
34. 10.1126/scitranslmed.300709510.1126/scitranslmed.3007095 ↗
35. 10.1007/s00216-023-04805-510.1007/s00216-023-04805-5 ↗
36. 10.3390/bios1307072610.3390/bios13070726 ↗
37. 10.1002/advs.20230656010.1002/advs.202306560 ↗
38. 10.30574/wjbphs.2025.21.1.004710.30574/wjbphs.2025.21.1.0047 ↗
39. Ray S, Ray S, D’souza R, et al. Nanotechniques and proteomics: an integrated platform for diagnostics,Targeted Therapeutics and Personalized Medicine Current Pharmacogenomics and Personalized Medicine. 2011;9(4):264–285
40. 10.3389/fmicb.2025.150749110.3389/fmicb.2025.1507491 ↗
41. 10.1039/c9an02041a10.1039/c9an02041a ↗
42. 10.1016/j.carbpol.2019.11546310.1016/j.carbpol.2019.115463 ↗
43. 10.1002/advs.20180088010.1002/advs.201800880 ↗
44. 10.3390/bios1510063910.3390/bios15100639 ↗
45. 10.3389/fcell.2023.116201510.3389/fcell.2023.1162015 ↗
46. 10.3389/fbioe.2023.114152310.3389/fbioe.2023.1141523 ↗
47. Schulz MC Sargis RM. Inappropriately sweet: environmental endocrine-disrupting chemicals and the diabetes pandemic. Adv Pharmacol. (2021);92:419–456 doi: 10.1016/bs.apha.2021.04.002.10.1016/bs.apha.2021.04.002 ↗
48. 10.1039/D2SD00156J10.1039/D2SD00156J ↗
49. 10.3389/fbioe.2024.134762510.3389/fbioe.2024.1347625 ↗
50. 10.1186/s13098-024-01317-910.1186/s13098-024-01317-9 ↗
51. 10.55730/1300-0144.611910.55730/1300-0144.6119 ↗
52. 10.1371/journal.pone.012033010.1371/journal.pone.0120330 ↗
53. 10.1016/j.bbrep.2024.10185210.1016/j.bbrep.2024.101852 ↗
54. 10.3390/molecules2104042110.3390/molecules21040421 ↗
55. 10.1021/jacs.5b0494210.1021/jacs.5b04942 ↗
56. 10.3791/5681410.3791/56814 ↗
57. 10.3390/s2408257010.3390/s24082570 ↗
58. 10.3390/coatings1602016410.3390/coatings16020164 ↗
59. 10.1080/14737159.2025.246796910.1080/14737159.2025.2467969 ↗
60. 10.62951/ijph.v1i3.6810.62951/ijph.v1i3.68 ↗
61. 10.3390/biomedicines1212275010.3390/biomedicines12122750 ↗
62. 10.1002/adma.20200610410.1002/adma.202006104 ↗
63. 10.69709/BIOMATC.2024.13100610.69709/BIOMATC.2024.131006 ↗
64. 10.1002/msj.2005410.1002/msj.20054 ↗
65. 10.58578/mikailalsys.v2i3.390710.58578/mikailalsys.v2i3.3907 ↗
66. 10.1021/acsnano.1c0049710.1021/acsnano.1c00497 ↗
67. 10.1111/joim.1364010.1111/joim.13640 ↗